Clinical trial
Study to Evaluate the Safety of Twice Daily Oral Carvedilol
NCT00129363 · Shaddy, Robert, M.D., Other · Completed
Key facts
| NCT number | NCT00129363 |
|---|---|
| Title | Study to Evaluate the Safety of Twice Daily Oral Carvedilol |
| Official title | A Multicenter, Open Label Extension Study to Evaluate the Safety of Twice Daily Oral Carvedilol in Pediatric Patients With Chronic Heart Failure |
| Lead sponsor | Shaddy, Robert, M.D., Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | Carvedilol |
| Enrollment | 75 |
| Start date | Jan 1, 2002 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Aug 11, 2005 |
| Last update posted | Dec 25, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: